Healthcare staff are the group with the very best threat of COVID-19 transmission. The sickness of healthcare staff poses a threat to sufferers admitted to the hospital, colleagues and households in addition to their very own well being. On this examine, it was aimed to find out the chance evaluation and the elements related to threat standing of an college hospital healthcare staff after dangerous COVID-19 contact. The info of the descriptive examine have been obtained from 773 follow-up information of 555 healthcare staff who utilized with COVID-19 dangerous contact between 06.04-10.05.2020. With the bodily enchancment of the remaining areas of the staff and the association of the breaks, the dangerous contact between colleagues within the social areas shall be lowered.

Workers who have been optimistic for RT-PCR evaluated as “sufferers” and others as “dangerous contact”. Danger evaluation was labeled as no threat, low, medium and excessive threat contact in keeping with the “Algorithm of Evaluation of Well being Employees with COVID-19 Contact” of the Ministry of Well being. The connection between the chance ranges of the individuals and their demographic and office traits and their utilization of non-public safety have been evaluated. Imply, normal deviation, share, chi-square and ANOVA checks have been used within the evaluation of the information. The common age of the healthcare staff was decided as 34.4 ± 7.6 years. It was decided that 56.2% of those that had contact have been feminine, 62.9% have been married and 17.5% had a further illness.

It was decided that 45.6% of the dangerous contacts have been nurses, 18.4% have been supportive personnel and 16.9% have been medical doctors. Whereas 46.5% of the contacts have been discovered as medium, 28.0% low, 17.1% excessive threat and eight.4% threat free. 38.2% of dangerous contacts occurred whereas working in inner/surgical clinics. Whereas 66.0% of the staff had dangerous contact throughout affected person care and therapy, 25% had dangerous contact with colleagues in social settings. Excessive-risk contact was larger in social relations between workers. The supply of the contact was a colleague in 73.2% of the staff.

The common age of high-risk workers was smaller than these of low-risk. Whereas 54.5% of the staff wore surgical masks throughout contact, 67.8% of the sufferers didn’t have a masks. Of 555 workers adopted, 37 (6.7%) have been recognized as COVID-19; 48.6% of the sufferers have been nurses and 18.9% have been medical doctors. It was decided that 48.6% of the healthcare staff have been working within the COVID-19 service, outpatient clinic or intensive care unit on the time of analysis. The supply of the an infection was regarded as a colleague in 51.6% of the sufferers. COVID-19 was extra widespread in nurses and medical doctors.

It was decided that dangerous contact additionally occurred in companies apart from the models the place COVID-19 sufferers have been handled and dangerous contact usually passed off whereas offering healthcare to the sufferers and through social relations between the staff. Unprotected contact of the staff with one another within the office was recognized as an essential threat supply. Insufficient use of non-public protecting tools by healthcare staff led to a rise in medium and excessive threat contacts. The usage of masks by sufferers and their family members in the course of the well being service supply and the correct use of non-public protecting tools by healthcare professionals will scale back the chance.

Challenges for bronchial asthma models in response to COVID-19: a qualitative group dynamics evaluation

To develop a set of suggestions for the administration of extreme bronchial asthma throughout COVID-19 pandemic. Eleven pneumologists and allergologists who have been employees members of formally accredited bronchial asthma models in Catalonia (Spain) participated in a cross-section examine primarily based on three 2-hour digital workshops (first: brainstorming, second: identification of impacts and challenges summarized in 10 matters, third: institution of ultimate suggestions by consensus).

Impacts and challenges recognized have been enchancment of referral protocols between completely different ranges of care; evaluation of the minimal variety of perform checks to be carried out and promote the efficiency of spirometry in major care; implementation of videoconferencing, cellular apps, phone calls, or integral digital platforms for the follow-up of sufferers, and definition of the mannequin of care (face-to-face, telematics, combined) in keeping with the affected person’s particular person wants; self-administration of biologics for domiciliary therapy; and empowerment of the position of nursing and hospital pharmacy specifically for follow-up and self-administration of biologics.

Alpha-bungarotoxin, CF640r
9-00004	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF488a
9-00005	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 500uG

Alpha-bungarotoxin CF488a
9-00005	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF568
9-00006	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 500uG

Alpha-bungarotoxin, CF568
9-00006	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF594
9-00007	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 500uG

Alpha-bungarotoxin CF594
9-00007	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF633
9-00009	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 500uG

Alpha-bungarotoxin, CF633
9-00009	Biotium	EUR 592.80 EUR 193.20	500uG 100uG
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin
00010-1	Biotium	1MG	EUR 201.6
Description: Minimum order quantity: 1 unit of 1MG

Fluorescein-Alpha-bungarotoxin
00011	Biotium	500uG	EUR 440.4
Description: Minimum order quantity: 1 unit of 500uG

Tetramethylrhodamine-Alpha-bungarotoxin
00012	Biotium	500uG	EUR 459.6
Description: Minimum order quantity: 1 unit of 500uG

Fluorescein-alpha-bungarotoxin: (10x50ug)
00013	Biotium	10ST	EUR 500.4
Description: Minimum order quantity: 1 unit of 10ST

Tetramethylrhodamine-alpha-bungarotoxin: (10x50ug)
00014	Biotium	10ST	EUR 559.2
Description: Minimum order quantity: 1 unit of 10ST

Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (500ug)
00015	Biotium	500uG	EUR 559.2
Description: Minimum order quantity: 1 unit of 500uG

Sulforhodamine 101-a-bungarotoxin (Texas Red--a-bungarotoxin): (10x50ug)
00016	Biotium	10ST	EUR 627.6
Description: Minimum order quantity: 1 unit of 10ST

Biotin-xx-a-bungarotoxin
00017	Biotium	500uG	EUR 519.6
Description: Minimum order quantity: 1 unit of 500uG

Alpha-Bungarotoxin, CF555 conjugate
9-00018	Biotium	EUR 592.80 EUR 193.20	500uG 100ug
Description: Minimum order quantity: 1 unit of 500uG

Alpha-Bungarotoxin, CF555 conjugate
9-00018	Biotium	EUR 592.80 EUR 193.20	500uG 100ug
Description: Minimum order quantity: 1 unit of 100ug

Biotin-cAMP, diisopropylethylammonium salt:
00020	Biotium	1MG	EUR 376.8
Description: Minimum order quantity: 1 unit of 1MG

Biotin-cAMP, diisopropylethylammonium salt: (20x50ug)
00020-1	Biotium	20ST	EUR 501.6
Description: Minimum order quantity: 1 unit of 20ST

Biotin-cGMP, diisopropylethylammonium salt:
00021	Biotium	1MG	EUR 412.8
Description: Minimum order quantity: 1 unit of 1MG

Biotin-cGMP, diisopropylethylammonium salt: (20x50ug)
00021-1	Biotium	20ST	EUR 537.6
Description: Minimum order quantity: 1 unit of 20ST

Cyanine 644-cAMP:
00022	Biotium	1MG	EUR 589.2
Description: Minimum order quantity: 1 unit of 1MG

Cyanine 644-cAMP: (20x50ug)
00022-1	Biotium	20ST	EUR 750
Description: Minimum order quantity: 1 unit of 20ST

Fluorescein Methotrexate, triammonium salt:
00023	Biotium	1MG	EUR 337.2
Description: Minimum order quantity: 1 unit of 1MG

Staurosporine
00025	Biotium	100uG	EUR 166.8
Description: Minimum order quantity: 1 unit of 100uG

Alpha-bungarotoxin, CF543
00026	Biotium	500uG	EUR 592.8
Description: Minimum order quantity: 1 unit of 500uG

Rhodamine phalloidin 300u
00027	Biotium	300	EUR 414
Description: Minimum order quantity: 1 unit of 300

Biotin-xx-phalloidin
00028	Biotium	100U	EUR 513.6
Description: Minimum order quantity: 1 unit of 100U

Fluorescein-phalloidin
00030	Biotium	300U	EUR 414
Description: Minimum order quantity: 1 unit of 300U

Rhodamine 110 phalloidin
00032	Biotium	300ST	EUR 414
Description: Minimum order quantity: 1 unit of 300ST

Sulforhodamine 101 (Texas-Red) Phalloidin
00033	Biotium	300EU	EUR 414
Description: Minimum order quantity: 1 unit of 300EU

Phalloidin, CF405M
00034	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF405M
00034-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

CF488A-cAMP
00036	Biotium	100ug	EUR 206.4
Description: Minimum order quantity: 1 unit of 100ug

CF640R-cAMP
00037	Biotium	100ug	EUR 206.4
Description: Minimum order quantity: 1 unit of 100ug

Phalloidin, CF555
00040	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF555
00040-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF647
00041	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF647
00041-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF488A
00042	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF488A
00042-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF543
00043	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF543
00043-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF568
00044	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF568
00044-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF594
00045	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF594
00045-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF633
00046	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF633
00046-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF660R
00047	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF660R
00047-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF680R
00048	Biotium	300U	EUR 559.2
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF680R
00048-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF350
00049	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF350
00049-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF640R
00050	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF640R
00050-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF532
00051	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF532
00051-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF660C
00052	Biotium	300U	EUR 530.4
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF660C
00052-T	Biotium	50U	EUR 159.6
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF680
00053	Biotium	300U	EUR 559.2
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF680
00053-T	Biotium	50U	EUR 176.4
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF430
00054	Biotium	300U	EUR 538.8
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF430
00054-T	Biotium	50U	EUR 166.8
Description: Minimum order quantity: 1 unit of 50U

Phalloidin, CF440
00055	Biotium	300U	EUR 538.8
Description: Minimum order quantity: 1 unit of 300U

Phalloidin, CF440
00055-T	Biotium	50U	EUR 166.8
Description: Minimum order quantity: 1 unit of 50U

Cholera Toxin Subunit B, CF488A conjugate
00070	Biotium	100ug	EUR 313.2
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF568 conjugate
00071	Biotium	100ug	EUR 313.2
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF594 conjugate
00072	Biotium	100ug	EUR 313.2
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF640R conjugate
00073	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF532 conjugate
00074	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF543 conjugate
00075	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF620R conjugate
00076	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF633 conjugate
00077	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF660R conjugate
00078	Biotium	100ug	EUR 316.8
Description: Minimum order quantity: 1 unit of 100ug

Cholera Toxin Subunit B, CF680R conjugate
00079	Biotium	100ug	EUR 338.4
Description: Minimum order quantity: 1 unit of 100ug

Human Transferrin, CF488A conjugate
00081	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF543 conjugate
00082	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF568 conjugate
00083	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF594 conjugate
00084	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF640R conjugate
00085	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF680R conjugate
00086	Biotium	1mg	EUR 178.8
Description: Minimum order quantity: 1 unit of 1mg

Human Transferrin, CF750 conjugate
00087	Biotium	1mg	EUR 186
Description: Minimum order quantity: 1 unit of 1mg

HIV-1 tat recombinant antigen
00110-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 tat recombinant antigen
00110-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 GAG P24 Recombinant Antigen
00111-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 GAG P24 Recombinant Antigen
00111-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 nef recombinant antigen
00112-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 nef recombinant antigen
00112-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 env gp41 recombinant antigen
00113-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV-1 env gp41 recombinant antigen
00113-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV-2 GP 36 Recombinant Antigen
00114-V-01mg	Virogen	0,1 mg	EUR 321
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa

HIV-2 GP 36 Recombinant Antigen
00114-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa

HCV core recombinant antigen
00115-V-01mg	Virogen	0,1 mg	EUR 321
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa

HCV core recombinant antigen
00115-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa

HCV core recombinant antigen, Biotin conjugate
00115-V-B-01mg	Virogen	0,1 mg	EUR 321
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate.

HCV core recombinant antigen, Biotin conjugate
00115-V-B-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate.

HCV core recombinant antigen, FITC conjugate
00115-V-F-01mg	Virogen	0,1 mg	EUR 321
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate.

HCV core recombinant antigen, FITC conjugate
00115-V-F-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate.

HCV core recombinant antigen, Rhodamine
00115-V-R-01mg	Virogen	0,1 mg	EUR 321
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate.

HCV core recombinant antigen, Rhodamine
00115-V-R-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate.

HCV NS4 recombinant antigen NS4a+b
00116-V-01mg	Virogen	0,1 mg	EUR 321
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa.

HCV NS4 recombinant antigen NS4a+b
00116-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa.

HCV NS4 recombinant antigen NS4a+b, Biotin
00116-V-B-01mg	Virogen	0,1 mg	EUR 321
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate.

HCV NS4 recombinant antigen NS4a+b, Biotin
00116-V-B-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate.

HCV NS4 recombinant antigen NS4a+b, FITC
00116-V-F-01mg	Virogen	0,1 mg	EUR 321
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate.

HCV NS4 recombinant antigen NS4a+b, FITC
00116-V-F-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate.

HCV NS4 recombinant antigen NS4a+b, Rhodamine
00116-V-R-01mg	Virogen	0,1 mg	EUR 321
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate.

HCV NS4 recombinant antigen NS4a+b, Rhodamine
00116-V-R-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate.

HCV NS3 recombinant antigen
00117-V-01mg	Virogen	0,1 mg	EUR 321
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa

HCV NS3 recombinant antigen
00117-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa

HBV core recombinant antigen
00120-V-01mg	Virogen	0,1 mg	EUR 321
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa

HBV core recombinant antigen
00120-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa

HBV core recombinant antigen, Delta
00121-V-01mg	Virogen	0,1 mg	EUR 321
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa

HBV core recombinant antigen, Delta
00121-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa

HBV surface recombinant antigen HBsAg
00122-V-01mg	Virogen	0,1 mg	EUR 321
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant

HBV surface recombinant antigen HBsAg
00122-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant

HBV surface recombinant antigen HBsAg antigen
00123-V-01mg	Virogen	0,1 mg	EUR 321
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity

HBV surface recombinant antigen HBsAg antigen
00123-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity

HBV surface recombinant antigen HBsAg antigen
00124-V-01mg	Virogen	0,1 mg	EUR 321
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant

HBV surface recombinant antigen HBsAg antigen
00124-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant

HEV (Birma) ORF2 recombinant antigen
00131-V-01mg	Virogen	0,1 mg	EUR 321
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659.

HEV (Birma) ORF2 recombinant antigen
00131-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659.

HEV (Birma) ORF2 recombinant antigen
00132-V-01mg	Virogen	0,1 mg	EUR 321
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461.

HEV (Birma) ORF2 recombinant antigen
00132-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461.

AA 403-461 HEV Birma ORF2 Recombinant Antigen
00133-V-01mg	Virogen	0,1 mg	EUR 321
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123.

AA 403-461 HEV Birma ORF2 Recombinant Antigen
00133-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123.

T, Pallidum recombinant antigen p15
00141-V-01mg	Virogen	0,1 mg	EUR 321
Description: T. Pallidum recombinant antigen p15 (full length)

T, Pallidum recombinant antigen p15
00141-V-1000ug	Virogen	1000 ug	EUR 1539
Description: T. Pallidum recombinant antigen p15 (full length)

T, Pallidum recombinant antigen p17
00142-V-01mg	Virogen	0,1 mg	EUR 321
Description: T. Pallidum recombinant antigen p17 (full length)

T, Pallidum recombinant antigen p17
00142-V-1000ug	Virogen	1000 ug	EUR 1539
Description: T. Pallidum recombinant antigen p17 (full length)

T, Pallidum recombinant antigen p45
00143-V-01mg	Virogen	0,1 mg	EUR 321
Description: T. Pallidum recombinant antigen p45 (full length)

T, Pallidum recombinant antigen p45
00143-V-1000ug	Virogen	1000 ug	EUR 1539
Description: T. Pallidum recombinant antigen p45 (full length)

T, pallidum recombinant antigen TmpA
00144-V-01mg	Virogen	0,1 mg	EUR 321
Description: T. Pallidum recombinant antigen TmpA (full length)

T, pallidum recombinant antigen TmpA
00144-V-1000ug	Virogen	1000 ug	EUR 1539
Description: T. Pallidum recombinant antigen TmpA (full length)

HCV core 2-119aa recombinant antigen
00150-V-01mg	Virogen	0,1 mg	EUR 321
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

HCV core 2-119aa recombinant antigen
00150-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

HCV Core 24 Antigen
00151-V-01mg	Virogen	0,1 mg	EUR 321
Description: HCV core 24 antigen.

HCV Core 24 Antigen
00151-V-1000ug	Virogen	1000 ug	EUR 1539
Description: HCV core 24 antigen.

The primary suggestions included coordination between major care and specialised care session, optimization of lung perform testing, implementation of telemedicine, and the position of nursing and hospital pharmacy. The precise proposals in response to the impact of COVID-19 pandemic centered on 4 areas of curiosity (coordination between major care and specialised care, optimization of lung perform testing, implementation of telemedicine, and empowerment of the position of nursing and hospital pharmacy) could also be generalized to different well being care settings, and assist to introduce new methods of caring bronchial asthma sufferers within the COVID-19 context.